Table 5 Antibiotic Susceptibility Patterns of Gram-Negative Bacteria isolated from newborn suspected of sepsis at Hawassa University Comprehensive Specialized Hospital February 2021 to November 2021 (n = 108).

From: Bacterial etiology and risk factors among newborns suspected of sepsis at Hawassa, Ethiopia

Bacteria

Susceptibility profile of n (%)

 

AMK

CEP

CRO

CAZ

CIP

CHL

AMC

IMP

MER

CN

SXT

TOB

PIP/TAZ

 

Klebsiella species* (n = 61)

R

18 (29.5)

61 (100)

59 (96.7)

61 (100)

5 (8.2)

12 (19.7)

60 (98.4)

4 (6.5)

5 (8.2)

22 (36.1)

57 (93.5)

ND

ND

I

3 (4.9)

1 (1.6)

1 (1.6)

ND

ND

S

43 (70.5)

2 (3.3)

53 (86.9)

49 (80.3)

57 (93.5)

56 (91.8)

38 (62.3)

4 (6.5)

ND

ND

Acinetobacter species (n = 16)

R

6 (37.5)

16 (100)

14 (87.5)

15 (93.7)

5 (31.3)

10 (62.5)

16 (100)

6 (37.5)

5 (31.3)

5 (31.3)

11 (68.7)

4 (25)

3 (18.8)

I

1 (6.3)

1 (6.3)

2 (12.5)

1 (6.3)

1 (6.3)

2 (12.5)

1 (6.25)

1 (6.3)

1 (6.3)

1 (6.3)

S

10 (62.5)

1 (6.3)

9 (56.3)

5 (31.3)

9 (56.3)

9 (56.3)

10 (62.5)

4 (25)

11 (68.7)

12 (75)

Pseudomonas species (n = 11)

R

5 (45.5)

10 (90.9)

9 (81.8)

11 (100)

4 (36.4)

5 (45.5)

11 (100)

1 (9.1)

1 (9.1)

6 (54.5)

6 (54.5)

2 (18.2)

1 (9.1)

I

1 (9.1)

1 (9.1)

1 (9.1)

1 (9.1)

1 (9.1)

S

6 (54.5)

1 (9.1)

2 (18.2)

6 (54.5)

5 (45.5)

9 (81.8)

9 (81.8)

4 (36.4)

5 (45.5)

9 (81.8)

10 (90.9)

Escherichia coli (n = 7)

R

2 (28.6)

6 (85.7)

6 (85.7)

7 (100)

3 (42.8)

3 (42.9)

7 (100)

3 (42.9)

6 (85.7)

ND

ND

I

1 (14.3)

1 (14.2)

ND

ND

S

4 (57.1)

1 (14.3)

1 (14.3)

4 (57.1)

4 (57.2)

7 (100)

7 (100)

3 (42.9)

1 (14.3)

ND

ND

Citrobacter species (n = 1)

R

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

ND

ND

I

ND

ND

S

1 (100)

1 (100)

1 (100)

ND

ND

Serratia marcescens (n = 2)

R

2 (100)

2 (100)

2 (100)

2 (100)

2 (100)

2 (100)

2 (100)

ND

ND

I

ND

ND

S

2 (100)

2 (100)

2 (100)

2 (100)

ND

ND

Enterobacter aglemerans (n = 6)

R

5 (83.3)

6 (100)

6 (100)

1 (16.7)

6 (100)

5 (83.3)

3 (50)

ND

ND

I

ND

ND

S

6 (100)

1 (16.7)

6 (100)

5 (83.3)

6 (100)

6 (100)

1 (16.7)

3 (50)

ND

ND

Enterobacter Species (n = 4)

R

1 (25)

4 (100)

4 (100)

4 (100)

1 (25)

4 (100)

1 (25)

3 (75)

ND

ND

I

ND

ND

S

3 (75)

4 (100)

3 (75)

4 (100)

4 (100)

3 (75)

1 (25)

ND

ND

Total (n = 108)

R

34 (31.5)

105 (97.2)

101 (93.5)

107 (99.1)

18 (16.67)

35 (32.40)

107 (99.1)

11 (10.2)

11 (10.2)

45 (41.67)

87 (80.56)

6 (22.2)

4 (14.8)

I

1 (0.9)

1 (0.92)

1 (0.9)

6 (5.56)

2 (1.8)

1 (0.9)

2 (1.8)

3 (2.78)

4 (3.7)

1 (0.9)

1 (3.7)

1 (3.7)

S

73 (67.6)

3 (2.8)

6 (5.6)

84 (77.8)

71 (65.7)

95 (87.9)

94 (87.0)

59 (54.6)

20 (18.5)

20 (74.0)

22 (81.5)

  1. AMK Amikacin, CEP Cefepime, CN Gentamicin, CAZ Ceftazidime, AMC Amoxicillin-Clavulanate, CHL Chloramphenicol; CRO Ceftriaxone; CIP Ciprofloxacin; SXT Sulfamethoxazole-Trimethoprim; IMP Imipenem, MRO Meropenem, PRL/TAZ Piperacillin-Tazobactam, TOB Tobramycin R Resistant, I Intermediate, S Susceptible, ND Not determined.
  2. ** Klebsiella pneumoniae = 46, Klebsiella ozenae = 13, Klebsiella oxytoca = 2.